Received Feb 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | EN6205 | IM / RA |
Reported Symptoms: 10054112:HOSPITALISATON; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084401:COVID-19 RESPIRATORY INFECTION; Narrative: 68 year old male with PMH of ESRD s/p renal transplant in 2005 on MM, tacrolimus, and daily prednisone admitted for acute covid infection w/o hypoxia. Patient with sepsis by SIRS criteria, likely secondary to acute covid infection per 8/7/24 hospitalist note. Given the risk of progression/severe disease in chronically immunosuppressed patient, patient was started on empiric remdesivir. Patient discharged home after completing 5 days of IV antiviral. Other Relevant HX: PMH significant for Afib, DM2, HTN, hyperlipidemia, HFpEF, gout, BPH, IDA, and CKD s/p kidney transplant in 2008 on immunosuppression Other: Hospitalization for treatment of Covid infection s/p vaccination
Positive Covid-19 test CXR Chest CT Abdominal CT